Clin2
NCT05820893Possibly a fitRecruiting

Resistant potato starch for Gulf War gut and fatigue

Gulf War Illness

Part of Injuries & trauma clinical trials.

This Phase 2 study tests whether resistant potato starch can improve Gulf War illness (GWI), especially gut symptoms and fatigue, in older adults. You may be asked to follow a study plan and provide stool samples, while avoiding certain medications and recent infections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
52 people
Ages
50 years to 85 years
Study type
Interventional

Who can take part

  • Be able to sign consent and follow the study steps for the whole study, including stool sample collection
  • Have Gulf War illness symptoms for at least 6 months, including fatigue, plus gut or other symptom areas
  • Have deployment history during Desert Storm or Desert Shield and be between 50 and 85 years old
  • Agree to avoid pregnancy or breastfeeding during the study
  • Do not have certain recent risks: COVID infection in the last 60 days/long COVID, recent antibiotics, or recent fecal microbiota transplant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05972291Recruiting
Study gut changes in Gulf War illness with chronic stomach symptoms

This study looks at what’s driving Gulf War illness, focusing on gut symptoms like belly pain, diarrhea, and bloating. It may help researchers test approaches aimed at gut barrier function in eligible veterans.

Memphis, Tennessee
NCT05675878Recruiting· Phase 3
Testing a specific diet for Gulf War illness

This Phase 3 study tests whether following a study diet can improve symptoms of Gulf War illness. It may help people by confirming whether diet changes are an effective treatment.

Washington D.C., District of Columbia
NCT05367245Recruiting· Phase 2
Butyrate supplement for Gulf War illness symptoms

This Phase 2 study tests whether a calcium–magnesium butyrate supplement can reduce symptoms of Gulf War Illness (GWI), especially by targeting gut and immune-related pathways. You may be eligible if you’re a Gulf War–era veteran with moderate-to-severe physical symptoms and no conditions or medicines that could explain them instead.

Long Beach, California
NCT05243290Recruiting
Nicotinamide riboside for Gulf War illness

This trial studies whether nicotinamide riboside (a vitamin-like substance related to vitamin B3) can improve symptoms of Gulf War illness in eligible Gulf War veterans. If you qualify, you may be asked to take the supplement and complete symptom assessments during the study.

Fort Lauderdale, Florida
NCT05736146Recruiting
Testing Gulf War illness blood markers for better diagnosis

This study checks blood tests to see whether they can help confirm Gulf War illness. If you qualify as having Gulf War illness (or are a similar Gulf War veteran without it), your blood and health information may be used to validate these marker tests.

Palo Alto, California
NCT04927338Recruiting· Phase 2
Bacopa supplement study for Gulf War illness symptoms

This trial tests whether Bacopa (a herbal supplement) can improve symptoms of Gulf War Illness (GWI). You may be eligible if you served in the Gulf War and still have ongoing, hard-to-explain fatigue and related symptoms.

Davie, Florida

Hear when a new Gulf War Illness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.